Please Note: This trial is no longer enrolling new participants
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
| Protocol No. | PHO-PRADHAN-COG-ACNS1422- | Scope | National |
|---|---|---|---|
| Principal Investigator | Sandeep Batra | Treatment Type | Treatment |
| Age Group | Children | Phase | Phase II |
